Used in pharmaceutical research as a nicotinic acetylcholine receptor modulator. Shows potential in developing treatments for neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Acts by selectively binding to neuronal receptors involved in cognitive function and neurotransmitter release. Also investigated for use in pain management due to its influence on central nervous system signaling pathways. Its structure supports high blood-brain barrier penetration, making it suitable for central nervous system-targeted therapies.